Acute toxicity and tolerability of anthracycline-based chemotherapy regimens in older versus younger patients with breast cancer: real-world data-Reference-Cited by-同舟云学术

Acute toxicity and tolerability of anthracycline-based chemotherapy regimens in older versus younger patients with breast cancer: real-world data

Published:2020-09-11 Issue:5 Volume:29 Page:2347-2353
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Monteiro Ana Raquel^ORCID,Garcia Ana Rita,Póvoa Sara,Soares Rita Félix,Macedo Filipa,Pereira Tatiana Cunha,Domingues Isabel,Pazos Isabel,Sousa Gabriela

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-020-05766-6.pdf

Reference9 articles.

1. Cancer of the Breast (Female) - SEER Stat Fact Sheets [Internet]. http://seer.cancer.gov/statfacts/html/breast.html. Accessed April 2020

2. Pondé N, Dal Lago L, Azim HA Jr (2016) Adjuvant chemotherapy in elderly patients with breast cancer: key challenges. Expert Rev Anticancer Ther 16(6):661–671

3. Freedman RA (2015) Treatment of breast cancer in the elderly. Curr Oncol Rep 17(11):51

4. Westphal T, Rinnerthaler G, Mlineritsch B (2016) Adjuvant medical treatment for breast cancer in elderly and old women. Memo. 9:17–19

5. Malik MK, Tartter PI, Belfer R (2013) Undertreated breast cancer in the elderly. J Cancer Epidemiol 2013:893104

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study;Clinical and Experimental Medicine;2023-08-27

2. Patient‐reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment;Cancer Medicine;2023-08-08

3. Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER–Medicare study;European Journal of Cancer;2023-05

4. The effects of low‐dose anthracycline‐based chemotherapy on the levels of serum NT‐proBNP level and left ventricular systolic and diastolic dysfunctions: A prospective observational study;Health Science Reports;2022-09

5. GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients;World Journal of Surgical Oncology;2022-06-22